ABPI Board
As a member organisation, we are led by our members who are actively involved in all the core areas of our activity, as well as helping to form the strategy and direction for the ABPI.
The ABPI Board comprises of individuals who are elected by members to represent the industry; and up to five people who are co-opted by the Board.
ABPI President and ABPI Vice President
ABPI Board Members
Steve Allan
CSL
Şeyda Atadan Memiş
Takeda UK & Ireland
Sebnem Avsar Tuna
Novo Nordisk UK
Roz Bekker
Johnson & Johnson
Ralph Blom
Chiesi UK & Ireland
Kylie Bromley
Biogen UK & Ireland
Mike Crosher
Chugai UK & Ireland
Tomer Feffer
Bayer
Sharon Hall
Sobi UK & Ireland
Steve Hopkinson
AbbVie UK
Doina Ionescu
Merck, UK & Ireland
Andrew Jackson
Lundbeck UK & Ireland
Johan Kahlström
Novartis, UK & Ireland
Tom Keith-Roach
AstraZeneca UK
Ben Lucas
MSD UK & Ireland
John McGinley
Pfizer UK
Ahmed Moussa
Sanofi UK & IE
Guy Oliver
Bristol Myers Squibb UK & Ireland
Ioana Parsons
Ipsen UK & Ireland
Richard Price
Amgen
Sandra Ramirez
Astellas
Nico Reynders
UCB UK
Kate Rowbotham
Roche UK
Chris Stokes
Eli Lilly and Company UK, Ireland & Northern Europe
Maria Tereno
Boehringer Ingelheim UK & IE
Peter Wickersham
Gilead UK & Ireland
Work at the ABPI
People who work for the ABPI make a difference. We are at the heart of a multi-billion pound pharmaceutical industry. Roles at the ABPI range from close liaison with Government and the NHS to working with education organisations and the media.
Last reviewed date: 01 May 2026
Next review date: 01 May 2027